Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Kiniksa Pharmaceuticals, Ltd. KNSA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • BM • USD

SharesGrow Score
69/100
2/7 Pass
SharesGrow Intrinsic Value
$61.87
+31.9%
Analyst Price Target
$55.67
+18.6%

Kiniksa Pharmaceuticals, Ltd. (KNSA) has 12 identified peers for comparison in the Healthcare sector. Peers include ACLX, BOLT, CERE, CGEM, CHRS, COGT and others.

KNSA has a market capitalization of $3.48B, compared to an average peer market cap of $3.35B.

People Also View

KRTX
KRTX
Karuna Therapeutics, Inc.
$329.83
+0.03%
 CERE
CERE
Cerevel Therapeutics Holdings, Inc.
$44.96
+0.74%
 NUVL
NUVL
Nuvalent, Inc.
$105.02
+1.28%
 ACLX
ACLX
Arcellx, Inc.
$114.89
+0.02%
 COGT
COGT
Cogent Biosciences, Inc.
$36.49
-0.08%
 GPCR
GPCR
Structure Therapeutics Inc.
$53.19
-1.95%
 DAWN
DAWN
Day One Biopharmaceuticals, Inc.
$21.46
-0.14%
 VTYX
VTYX
Ventyx Biosciences, Inc.
$14.00
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message